$1.19
+0.00 (+0.01%)
Open$1.20
Previous Close$1.19
Day High$1.20
Day Low$1.19
52W High$4.87
52W Low$0.85
Volume—
Avg Volume105.1K
Market Cap15.64M
P/E Ratio—
EPS$-2.46
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,469.7% upside
Current
$1.19
$1.19
Target
$42.48
$42.48
$23.35
$42.48 avg
$52.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.32M | 1.18M | 4.21M |
| Net Income | -30,830,931 | -17,884,542 | -76,163 |
| Profit Margin | -2,344.6% | -1,605.8% | -1.8% |
| EBITDA | -31,615,356 | -17,808,595 | -73,642 |
| Free Cash Flow | — | — | -41,548 |
| Rev Growth | +131.9% | +78.7% | +17.4% |
| Debt/Equity | 250.29 | 250.29 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |